Baseline characteristics of participants presenting with or without peripheral artery disease (PAD)...
-
Upload
virginia-reeves -
Category
Documents
-
view
219 -
download
0
description
Transcript of Baseline characteristics of participants presenting with or without peripheral artery disease (PAD)...
Baseline characteristics of participants presenting with or without peripheral artery disease (PAD)
Heart Protection Study Group J Vasc Surg 2007;45:645-54
Effects of simvastatin allocation on first major coronary event, stroke, or revascularization in participants
presenting with or without peripheral artery disease
Heart Protection Study Group J Vasc Surg 2007;45:645-54
Absolute effects of simvastatin allocation on 5-year rates of first major vascular events among participants subdivided by prior PAD
Heart Protection Study Group J Vasc Surg 2007;45:645-54
Effects of simvastatin allocation on major vascular events in prior disease subgroups
Heart Protection Study Group J Vasc Surg 2007;45:645-54
Effects of simvastatin allocation on first major vascular event in participants with or without PAD subdivided by other presenting features
Heart Protection Study Group J Vasc Surg 2007;45:645-54
Effects of simvastatin allocation on first and all major vascular events in participants with or without PAD
Heart Protection Study Group J Vasc Surg 2007;45:645-54
Effects of simvastatin allocation on first peripheral vascular event subdivided by presenting features
Heart Protection Study Group J Vasc Surg 2007;45:645-54
Average use of statin (study or non-study), and average plasma LDL cholesterol concentrations, during follow-up. Table online only
Heart Protection Study Group J Vasc Surg 2007;45:645-54
DISCUSSION
Heart Protection Study Group J Vasc Surg 2007;45:645-54
INVITED COMMENTARYWilliam R. Hiatt
Heart Protection Study Group J Vasc Surg 2007;45:645-54